Crossmark

How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience

Crossref DOI link: https://doi.org/10.1186/s12969-023-00860-5

Published Online: 2023-07-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ozdel, Semanur http://orcid.org/0000-0001-5602-4595
Sönmez, Hafize Emine

Çağlayan, Şengül

Akgün, Özlem

Aydın, Tuncay

Baba, Özge

Bağrul, İlknur

Yener, Gülçin Otar

Öztürk, Kübra

Demir, Ferhat

Yıldırım, Deniz Gezgin

Karadağ, Şerife Gül

Bağlan, Esra

Çakan, Mustafa

Kalyoncu, Mukaddes

Makay, Balahan Bora

Ünsal, Şevket Erbil

Bakkaloğlu, Sevcan

Bülbül, Mehmet

Sözeri, Betül

Ayaz, Nuray Aktay
License Information

Text and Data Mining valid from 2023-07-20

Version of Record valid from 2023-07-20
More Information

Article History

Received: 25 May 2023

Accepted: 17 July 2023

First Online: 20 July 2023

Declarations

:

: Because of the retrospective nature of the study, obtaining written informed consent from the patients was not required. Ethics committee approval (date/no:25 June 2020/GP-0.01/251) was obtained from the Umraniye Research and Training Hospital, Ethics Committe of Clinical Trials.This article does not contain any studies with human participants or animals performed by any of the authors.

: Not applicable.

: No conflict of intrest.

Document is current

Any future updates will be listed below